Infection-Chronic Disease Link

In "The Infection-Chronic Disease Link Strengthens,"1 there are comments about the utility of Koch's postulates: "The first criterion remains--the microbial culprit must be present. But the requirements to culture microorganisms and demonstrate infectivity may have become obsolete." This would almost seem to go against the scientific method, since it seems to imply that testing one's hypothesis does not require exhaustive attempts at falsification, the fundamental basis of the scientific

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In "The Infection-Chronic Disease Link Strengthens,"1 there are comments about the utility of Koch's postulates: "The first criterion remains--the microbial culprit must be present. But the requirements to culture microorganisms and demonstrate infectivity may have become obsolete."

This would almost seem to go against the scientific method, since it seems to imply that testing one's hypothesis does not require exhaustive attempts at falsification, the fundamental basis of the scientific method. Why would scientists NOT want to demonstrate infectivity of an agent that they propose is indeed infectious? Koch's postulates have served us very well for over 100 years. Is it that they are really obsolete, or do scientists really need an explanation for their inability to demonstrate infectivity of their hypothetical pathogenic microbes? Are there too many dollars at stake to apply standard, rigorous scientific standards?

I think it is a slippery slope to start dismissing established postulates, which essentially ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Todd Miller

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo